MINGYANG TECHNOLOGY
837663
Shanghai Weihong Electronic Technology
300508
Shenzhen Intellifusion Technologies
688343
4
Est Tools Co., Ltd.
300488
5
Jiangyin Pivot Automotive Products
301181
US Stock MarketDetailed Quotes
MYGN Myriad Genetics
- 11.740
- -2.040-14.80%
Close Feb 25 16:00 ET
- 11.740
- 0.0000.00%
Post 16:51 ET
1.07BMarket Cap-8.33P/E (TTM)
12.280High9.760Low2.72MVolume10.320Open13.780Pre Close31.78MTurnover3.04%Turnover RatioLossP/E (Static)91.30MShares29.30052wk High1.53P/B1.05BFloat Cap9.76052wk Low--Dividend TTM89.37MShs Float69.000Historical High--Div YieldTTM18.29%Amplitude1.438Historical Low11.692Avg Price1Lot Size
Myriad Genetics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.21%837.6M | 7.12%210.6M | 11.15%213.3M | 15.26%211.5M | 11.59%202.2M | 11.03%753.2M | 10.57%196.6M | 22.70%191.9M | 2.34%183.5M | 9.88%181.2M |
| Operating revenue | 11.21%837.6M | 7.12%210.6M | 11.15%213.3M | 15.26%211.5M | 11.59%202.2M | 11.03%753.2M | 10.57%196.6M | 22.70%191.9M | 2.34%183.5M | 9.88%181.2M |
| Cost of revenue | 6.77%252.2M | -3.08%59.7M | 10.24%63.5M | 11.42%64.4M | 9.12%64.6M | 16.93%236.2M | 14.29%61.6M | 14.29%57.6M | 16.30%57.8M | 23.33%59.2M |
| Gross profit | 13.23%585.4M | 11.78%150.9M | 11.54%149.8M | 17.02%147.1M | 12.79%137.6M | 8.52%517M | 8.96%135M | 26.70%134.3M | -3.01%125.7M | 4.36%122M |
| Operating expense | 1.78%673.4M | 1.69%168.2M | 4.68%167.6M | 6.24%172M | -4.99%165.5M | 10.25%661.6M | -2.65%165.4M | 6.03%160.1M | 9.84%161.9M | 32.17%174.2M |
| Selling and administrative expenses | -2.25%560M | -4.09%138.5M | 2.20%139.1M | 2.99%144.9M | -7.32%140.6M | 11.31%572.9M | -1.43%144.4M | 4.29%136.1M | 10.70%140.7M | 37.16%151.7M |
| -Selling and marketing expense | --284.1M | --72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | -51.84%275.9M | -53.95%66.5M | 2.20%139.1M | ---- | ---- | 11.31%572.9M | -1.43%144.4M | 4.29%136.1M | ---- | ---- |
| Research and development costs | 27.85%113.4M | 41.43%29.7M | 18.75%28.5M | 27.83%27.1M | 10.67%24.9M | 3.86%88.7M | -10.26%21M | 17.07%24M | 4.43%21.2M | 6.13%22.5M |
| Operating profit | 39.14%-88M | 43.09%-17.3M | 31.01%-17.8M | 31.22%-24.9M | 46.55%-27.9M | -16.90%-144.6M | 33.91%-30.4M | 42.67%-25.8M | -103.37%-36.2M | -250.34%-52.2M |
| Net non-operating interest income expense | -175.00%-1.1M | -100.00%-400K | 0.00%-400K | -400K | -50.00%100K | 33.33%-400K | -300.00%-200K | -233.33%-400K | 0 | 125.00%200K |
| Non-operating interest income | -32.00%1.7M | -57.14%300K | -33.33%400K | -20.00%400K | -14.29%600K | -3.85%2.5M | -30.00%700K | -45.45%600K | 25.00%500K | 600.00%700K |
| Non-operating interest expense | -3.45%2.8M | -22.22%700K | -20.00%800K | 60.00%800K | 0.00%500K | -9.38%2.9M | 0.00%900K | 25.00%1M | -16.67%500K | -44.44%500K |
| Other net income (expense) | 70.65%-34.4M | -1,158.82%-21.4M | 91.43%-3M | 85.11%-11.9M | 416.67%1.9M | -619.02%-117.2M | 72.58%-1.7M | -7,100.00%-35M | -80,000.00%-79.9M | 94.39%-600K |
| Special income (charges) | 68.53%-35.5M | -2,070.00%-21.7M | 93.59%-2.2M | 85.03%-11.6M | ---- | -567.46%-112.8M | 83.87%-1M | ---34.3M | ---77.5M | ---- |
| -Less:Impairment of capital assets | --56.8M | --43M | --2.2M | --11.6M | ---- | --0 | --0 | --0 | --0 | ---- |
| -Less:Other special charges | -118.88%-21.3M | -2,230.00%-21.3M | ---- | ---- | ---- | --112.8M | --1M | --34.3M | --77.5M | ---- |
| Other non- operating income (expenses) | 125.00%1.1M | 142.86%300K | -14.29%-800K | 87.50%-300K | 416.67%1.9M | -833.33%-4.4M | ---700K | -240.00%-700K | -2,500.00%-2.4M | ---600K |
| Income before tax | 52.90%-123.5M | -21.05%-39.1M | 65.36%-21.2M | 67.96%-37.2M | 50.76%-25.9M | -86.49%-262.2M | 38.00%-32.3M | -38.46%-61.2M | -548.60%-116.1M | -99.24%-52.6M |
| Income tax | 245.45%3.8M | 409.09%3.4M | 800.00%900K | -500K | -95.24%100K | 103.85%1.1M | 88.78%-1.1M | 101.10%100K | 0 | 135.59%2.1M |
| Net income | 51.65%-127.3M | -36.22%-42.5M | 63.95%-22.1M | 68.39%-36.7M | 52.47%-26M | -135.09%-263.3M | 26.24%-31.2M | -74.64%-61.3M | -723.40%-116.1M | -166.83%-54.7M |
| Net income continuous Operations | 51.65%-127.3M | -36.22%-42.5M | 63.95%-22.1M | 68.39%-36.7M | 52.47%-26M | -135.09%-263.3M | 26.24%-31.2M | -74.64%-61.3M | -723.40%-116.1M | -166.83%-54.7M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 51.65%-127.3M | -36.22%-42.5M | 63.95%-22.1M | 68.39%-36.7M | 52.47%-26M | -135.09%-263.3M | 26.24%-31.2M | -74.64%-61.3M | -723.40%-116.1M | -166.83%-54.7M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 51.65%-127.3M | -36.22%-42.5M | 63.95%-22.1M | 68.39%-36.7M | 52.47%-26M | -135.09%-263.3M | 26.24%-31.2M | -74.64%-61.3M | -723.40%-116.1M | -166.83%-54.7M |
| Basic earnings per share | 55.66%-1.41 | -30.56%-0.47 | 68.00%-0.24 | 71.13%-0.41 | 56.72%-0.29 | -128.78%-3.18 | 30.77%-0.36 | -74.42%-0.75 | -688.89%-1.42 | -157.69%-0.67 |
| Diluted earnings per share | 55.66%-1.41 | -30.56%-0.47 | 68.00%-0.24 | 71.13%-0.41 | 56.72%-0.29 | -128.78%-3.18 | 30.77%-0.36 | -74.42%-0.75 | -688.89%-1.42 | -157.69%-0.67 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets.
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites